Talkspace, Inc. (TALK)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	194.36	187.59	150.05	119.57	113.67	76.19
Revenue Growth (YoY)	19.88%	25.02%	25.49%	5.19%	49.19%	99.56%
Cost of Revenue	113.91	108.3	81.82	65.82	56.26	30.69
Gross Profit	80.45	79.29	68.22	53.75	57.41	45.51
Selling, General & Admin	73.07	72.08	73.86	109.11	135.41	57.9
Research & Development	10.09	10.51	17.57	21.66	15.92	9.58
Operating Expenses	83.16	82.59	91.43	130.77	151.33	67.49
Operating Income	-2.7	-3.3	-23.21	-77.02	-93.92	-21.98
Interest Expense	-0.41	-0.41	-0.15	-	-	-0.36
Interest & Investment Income	7.15	6	5.3	0.61	31.23	-
Other Non Operating Income (Expenses)	0.15	0.15	-0.9	3.13	-	-
EBT Excluding Unusual Items	4.18	2.44	-18.96	-73.28	-62.7	-22.35
Impairment of Goodwill	-	-	-	-6.13	-	-
Other Unusual Items	-1.2	-1.2	-	-	-	-
Pretax Income	2.98	1.24	-18.96	-79.42	-62.7	-22.35
Income Tax Expense	0.05	0.09	0.22	0.25	0.05	0.02
Net Income	2.93	1.15	-19.18	-79.67	-62.74	-22.37
Net Income to Common	2.93	1.15	-19.18	-79.67	-62.74	-22.37
Shares Outstanding (Basic)	169	169	165	157	87	13
Shares Outstanding (Diluted)	178	176	165	157	87	13
Shares Change (YoY)	6.82%	6.94%	5.20%	80.79%	549.55%	5.01%
EPS (Basic)	0.02	0.01	-0.12	-0.51	-0.72	-1.67
EPS (Diluted)	0.02	0.01	-0.12	-0.51	-0.72	-1.67
Free Cash Flow	13.86	11.7	-16.39	-61.08	-66.37	-15.3
Free Cash Flow Per Share	0.08	0.07	-0.10	-0.39	-0.77	-1.15
Gross Margin	41.39%	42.27%	45.47%	44.95%	50.50%	59.73%
Operating Margin	-1.39%	-1.76%	-15.47%	-64.42%	-82.63%	-28.85%
Profit Margin	1.51%	0.61%	-12.78%	-66.63%	-55.20%	-29.36%
Free Cash Flow Margin	7.13%	6.24%	-10.93%	-51.08%	-58.39%	-20.08%
EBITDA	-1.38	-2.44	-22.01	-75.67	-91.95	-21.6
EBITDA Margin	-0.71%	-1.30%	-14.67%	-63.28%	-80.89%	-28.35%
D&A For EBITDA	1.32	0.86	1.2	1.36	1.97	0.38
EBIT	-2.7	-3.3	-23.21	-77.02	-93.92	-21.98
EBIT Margin	-1.39%	-1.76%	-15.47%	-64.42%	-82.63%	-28.85%
Effective Tax Rate	1.74%	7.57%	-	-	-	-

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q